Anatomy & Physiology Study Guide
29

Metabolism, Nutrition, and Thermoregulation

Slide deck, chapter 2930 slidesChapter outline and sourcesPractice questions

  1. 29.1

    The coenzyme ledger up to the electron transport chain

    • Glycolysis spends 2 ATP and makes 4, so the net is 2 ATP plus 2 NADH and 2 pyruvate per glucose.
    • Pyruvate dehydrogenase makes acetyl CoA, CO2 and NADH from each pyruvate, so 2 NADH per glucose.
    • One turn of the citric acid cycle gives 3 NADH, 1 FADH2 and 1 ATP (as GTP), and releases 2 CO2.
    • Each glucose gives two turns: 6 NADH, 2 FADH2, 2 ATP. Tally through the cycle: 10 NADH, 2 FADH2 and 4 ATP by substrate-level phosphorylation.

    Outcome

    1. 1Calculate the net ATP and reduced-coenzyme yield of glycolysis, pyruvate dehydrogenase and one turn of the citric acid cycle.
  2. 29.1

    Control points of glycolysis and the citric acid cycle

    • Phosphofructokinase-1 is the committed step of glycolysis: high ATP and citrate slow it, AMP and fructose 2,6-bisphosphate speed it.
    • Hexokinase has a higher affinity for glucose than glucokinase of the liver, so low-glucose states send glucose to tissues that need it.
    • Pyruvate dehydrogenase is the gate into the cycle and is inhibited by its own products, acetyl CoA and NADH, and by ATP.
    • Isocitrate dehydrogenase sets the pace of the cycle: ADP activates it, ATP and NADH inhibit it. Energy charge ties all three controls together.

    Outcome

    1. 2Identify the rate-limiting enzymes of glycolysis and the citric acid cycle and the allosteric or hormonal signals that regulate them.
  3. 29.1

    Electron transport and chemiosmotic ATP synthesis

    • NADH and FADH2 hand electrons to complexes in the inner mitochondrial membrane; O2 is the final acceptor and forms water.
    • Energy released along the chain pumps H+ into the intermembrane space, building a gradient across the inner membrane.
    • H+ flowing back through ATP synthase turns it and makes ATP from ADP and Pi; without O2 electron flow stops.
    • FADH2 enters at complex II, lower in the chain, so it yields about 1.5 ATP against about 2.5 for NADH (P/O ratios), giving about 30 to 32 ATP per glucose.
    • The total is 30 or 32 depending on the shuttle that carries glycolytic NADH into mitochondria; older texts use 3 and 2 ATP and give 36 or 38, and real yields are lower.

    Outcome

    1. 3Explain how the electron transport chain and chemiosmotic coupling make ATP, and estimate the total ATP per glucose under aerobic conditions.
  4. 29.1

    Anaerobic glycolysis and the Cori cycle

    • Without O2 the chain stops, NADH piles up, and pyruvate is reduced to lactate by lactate dehydrogenase, regenerating NAD+.
    • Glycolysis keeps running on the regenerated NAD+, but the yield is only the 2 ATP net per glucose; useful for seconds to minutes.
    • Red blood cells have no mitochondria and always make lactate; exercising muscle does the same when ATP demand outruns O2 delivery.
    • Lactate travels to the liver and is converted back to glucose (Cori cycle), which returns to the muscle; the liver pays the ATP cost.

    Outcome

    1. 4Compare aerobic with anaerobic glucose metabolism, including the fate of pyruvate, the role of lactate dehydrogenase and the Cori cycle.
  5. 29.1

    Glycogen and new glucose

    • Insulin drives glycogen synthesis in liver and muscle; glucagon (liver) and epinephrine break it down.
    • Liver glycogen is released as free glucose because the liver has glucose 6-phosphatase; it is largely used up after roughly 24 hours of fasting.
    • Muscle lacks glucose 6-phosphatase, so its glycogen feeds its own glycolysis and cannot raise blood glucose.
    • Gluconeogenesis (liver, kidney) uses pyruvate, lactate, glycerol and amino acids such as alanine and glutamine.
    • It bypasses irreversible glycolytic steps: PEPCK, fructose 1,6-bisphosphatase and glucose 6-phosphatase replace pyruvate kinase, PFK-1 and hexokinase.

    Outcome

    1. 5Describe glycogenesis, glycogenolysis and gluconeogenesis, including the organs, substrates and the differing fates of liver and muscle glycogen.
  6. 29.2

    Beta-oxidation and the carnitine shuttle

    • Triglycerides are hydrolyzed to glycerol and fatty acids; the fatty acid is activated to fatty acyl CoA in the cytosol.
    • Carnitine carries the acyl group across the inner mitochondrial membrane; this entry step is the regulated, rate-limiting point.
    • In the matrix, beta-oxidation clips two carbons at a time off the chain as acetyl CoA, also making FADH2 and NADH each round.
    • Palmitate (16 C) gives 8 acetyl CoA after 7 rounds and a net of about 106 ATP (2.5 and 1.5 per NADH and FADH2); the older 3 and 2 give Tortora's 129.

    Outcome

    1. 6Describe beta-oxidation of fatty acids, the carnitine shuttle as the rate-limiting step, and the ATP yield from palmitate.
  7. 29.2

    Ketogenesis: when acetyl CoA outruns the cycle

    • In fasting or untreated diabetes, fatty acid breakdown floods the liver with acetyl CoA while oxaloacetate is scarce.
    • Surplus acetyl CoA is condensed through HMG CoA into acetoacetate and beta-hydroxybutyrate, the main ketone in blood; acetone is exhaled.
    • Ketones are lipid-soluble and cross the blood-brain barrier; brain, heart and skeletal muscle convert them back to acetyl CoA.
    • The liver makes ketones but cannot burn them, so it exports them. Beta-hydroxybutyrate is about 0.1-0.4 mmol/L normally, 1-2 after 1-2 days of fasting, 5-7 after 2-3 weeks.

    Outcome

    1. 7Explain the conditions that drive ketogenesis in the liver and the use of ketone bodies by brain, heart and muscle.
  8. 29.2

    Lipoprotein classes and their routes

    • Chylomicrons form in intestinal cells, are about 85% triglyceride, and carry dietary lipid via lymph; apo C-2 activates lipoprotein lipase.
    • Remnants are taken up by the liver with apo E as the docking protein; VLDL is made by hepatocytes to export endogenous triglyceride.
    • As VLDL loses triglyceride it becomes LDL, which is half cholesterol and carries about 75% of blood cholesterol; apo B100 binds the LDL receptor.
    • HDL carries excess cholesterol from cells and blood to the liver; high HDL lowers coronary risk, excess LDL deposits cholesterol in arterial walls.

    Outcome

    1. 8Compare the lipoprotein classes (chylomicron, VLDL, IDL, LDL, HDL) by origin, main lipid, apolipoproteins and role in lipid transport.
  9. 29.2

    Making fatty acids and cholesterol

    • With ample glucose, acetyl CoA leaves the mitochondrion as citrate and is rebuilt in the cytosol into fatty acids, two carbons at a time.
    • Acetyl CoA carboxylase makes malonyl CoA, the committed step; insulin and citrate activate it, glucagon and AMPK inhibit it.
    • Malonyl CoA also blocks the carnitine shuttle, so fat is not made and burned in the same cell at once.
    • HMG-CoA reductase is the rate-limiting enzyme of cholesterol synthesis in hepatocytes and the target of statin drugs.
    • About 75% of blood cholesterol is made by the liver and other cells and about 25% comes from food (FDA).

    Outcome

    1. 9Describe fatty acid and cholesterol synthesis, including the regulation of acetyl CoA carboxylase and HMG-CoA reductase.
  10. 29.2

    Amino groups, ammonia and urea

    • Transamination moves an amino group to a keto acid, turning an amino acid into a keto acid and a new amino acid, using vitamin B6.
    • Deamination in hepatocytes strips the amino group from the carbon skeleton and releases ammonia (NH3).
    • Ammonia is highly toxic, so the liver converts it to urea, which is harmless and excreted by the kidney.
    • The urea cycle starts in the mitochondrial matrix and finishes in the cytosol; defects or liver failure raise ammonia and cause brain dysfunction.

    Outcome

    1. 10Explain deamination, transamination and the urea cycle and state why ammonia must be detoxified.
  11. 29.3

    Fed state: insulin builds stores

    • After a meal, rising glucose triggers beta cells to release insulin, the dominant hormone for up to about 4 hours.
    • Liver, muscle and adipose cells take up glucose; liver and muscle store glycogen, and surplus glucose becomes fat.
    • Adipose stores dietary fat from chylomicrons and VLDL as triglyceride; muscle uses amino acids for protein synthesis.
    • Most cells burn glucose; the brain depends on it at all times. Insulin also suppresses breakdown of glycogen, fat and protein.

    Outcome

    1. 11Describe fuel use by liver, adipose tissue, skeletal muscle, heart and brain in the absorptive state and the hormones that dominate it.
  12. 29.3

    Fasting state: holding blood glucose up

    • About 4 hours after a meal absorption is nearly done and glucose begins to fall; insulin drops, glucagon rises. This postabsorptive phase runs to roughly 18 hours.
    • Glucagon acts on the liver to break down glycogen and to start gluconeogenesis; epinephrine adds to this and drives lipolysis.
    • Lipolysis frees fatty acids for muscle and liver, sparing glucose for the nervous system and red blood cells, which cannot use fatty acids.
    • Glycerol and lactate feed gluconeogenesis; cortisol and growth hormone oppose insulin and support gluconeogenesis and lipolysis.

    Outcome

    1. 12Explain how glucagon, epinephrine, cortisol and falling insulin maintain blood glucose in the postabsorptive state.
  13. 29.3

    Counter-regulation and the hypoglycemia thresholds

    • When glucose falls, glucagon and epinephrine surge first; cortisol and growth hormone matter more in prolonged hypoglycemia.
    • Autonomic symptoms (sweating, tremor, palpitations, hunger) begin near 60 mg/dL; neuroglycopenic ones (confusion, seizures, coma) near 50 mg/dL.
    • In patients on insulin or sulfonylureas, a glucose below 70 mg/dL counts as hypoglycemia, and below 54 mg/dL is level 2.
    • Whipple triad confirms hypoglycemia in patients not on diabetes drugs: symptoms, a plasma glucose below about 55 mg/dL, and relief when sugar is given.

    Outcome

    1. 12Explain how glucagon, epinephrine, cortisol and falling insulin maintain blood glucose in the postabsorptive state.
  14. 29.3

    Starvation: from glycogen to ketones

    • Early: liver glycogen first (largely gone by about 24 hours), then gluconeogenesis from glycerol, lactate and amino acids, taken partly from muscle protein.
    • The brain needs about 100-120 g of glucose a day, more than glycogen alone can supply; in prolonged fasting the kidney provides about 40% of gluconeogenesis, mostly from glutamine.
    • Within 2 days ketones rise 100-300 times and supply roughly a third of brain fuel; by 40 days up to two thirds. Beta-hydroxybutyrate reaches about 5-7 mmol/L by 2-3 weeks.
    • Ketones reduce glucose use, lessen gluconeogenesis, and slow muscle protein loss to about 20 g daily.
    • Death follows when fat is spent and the body's proteins fall to about half normal. Priority order is brain glucose, then protein sparing.

    Outcome

    1. 13Compare the fuel sources and tissue priorities in the first day, in the first week and in prolonged starvation.
  15. 29.3

    Untreated type 1 diabetes: starving in a sea of glucose

    • Without insulin, glucose cannot enter muscle and fat, so cells behave as if fasting while blood glucose is high.
    • Lipolysis is unrestrained, the liver makes ketones from the acetyl CoA, and gluconeogenesis adds to the hyperglycemia.
    • Glucose above the renal threshold spills into urine and pulls water with it, causing dehydration.
    • Ketone acids lower blood pH (diabetic ketoacidosis); acetone gives a sweet breath. Respiratory quotient stays near the fat value, 0.7.

    Outcome

    1. 14Predict the metabolic consequences of insulin deficiency by comparing the fed state with untreated type 1 diabetes.
  16. 29.4

    Basal metabolic rate and total energy expenditure

    • BMR is the energy used at rest, fasting and thermoneutral; it is estimated from O2 use, since about the same heat comes per liter of O2.
    • BMR is about 60-70% of total daily expenditure; the thermic effect of food adds about 8-15% and activity the rest (Tortora gives 60%, 30-35% and 5-10%).
    • Raised by lean mass, thyroid hormone (the main regulator), sympathetic activity, fever and youth; lowered by age, female sex, starvation.
    • Each 1 C rise of core temperature raises metabolic rate about 10-13%, and BMR falls about 1-2% per decade from the twenties on, largely as muscle is lost.

    Outcome

    1. 15Define basal metabolic rate and list its determinants and methods of measurement.
  17. 29.4

    Respiratory quotient and indirect calorimetry

    • RQ is CO2 produced divided by O2 consumed; carbohydrate is 1.0, protein about 0.8, fat about 0.7.
    • Fat has a lower RQ because much of its O2 is used to combine with its excess hydrogen, so less CO2 forms.
    • Just after a meal RQ approaches 1.0; 8 to 10 hours later it nears 0.7 as carbohydrate is used up.
    • Untreated diabetes keeps RQ near 0.7 because cells cannot use carbohydrate without insulin.

    Outcome

    1. 15Define basal metabolic rate and list its determinants and methods of measurement.
  18. 29.4

    Hypothalamic thermostat and the response to cold

    • Preoptic area neurons fire faster as blood warms and slower as it cools; skin and hypothalamic thermoreceptors feed them.
    • They drive the heat-losing center in the hypothalamus and the heat-promoting center; core temperature is held near 37 C.
    • Cold: sympathetic vasoconstriction, epinephrine and norepinephrine, and shivering, which at maximum can raise heat production to four to five times normal.
    • The hypothalamus also releases TRH; the pituitary then releases TSH and thyroid hormones raise metabolic rate over hours to days.

    Outcome

    1. 16Explain how the hypothalamus senses and regulates body temperature and name the effector responses to heat and to cold.
  19. 29.4

    Response to heat

    • A warmer blood temperature stimulates the heat-losing center and inhibits the heat-promoting center.
    • Skin vessels dilate, so more blood reaches the skin and loses heat by radiation and conduction.
    • Sympathetic activation of sweat glands brings water to the skin, and evaporation cools it.
    • Metabolic rate falls and shivering is suppressed. Behavior, such as seeking shade or removing clothing, is also a powerful effector.

    Outcome

    1. 16Explain how the hypothalamus senses and regulates body temperature and name the effector responses to heat and to cold.
  20. 29.4

    Fever versus hyperthermia

    • Fever: pyrogens such as interleukin-1 induce prostaglandin E2 in the hypothalamus, which raises the set point.
    • Heat is conserved and made (chills, vasoconstriction) until the new set point is reached; core temperature is then defended there.
    • Aspirin-type antipyretics block prostaglandin formation, lowering the set point back so sweating and vasodilation resume.
    • Hyperthermia: set point unchanged but heat gain or production exceeds loss, as in heatstroke; antipyretics do not work and cooling is needed.
    • Heatstroke is hyperthermia above 40 C with confusion, seizures or coma; cold-water immersion is the preferred cooling and antipyretics are not recommended.

    Outcome

    1. 17Distinguish fever from hyperthermia by mechanism, set point and response to antipyretics.
  21. 29.4

    Four routes of heat loss

    • At rest in a 21 C room: radiation about 60%, evaporation about 22%, convection about 15%, conduction about 3%.
    • Radiation and conduction depend on the gradient between skin and surroundings; if surroundings are warmer, heat is gained.
    • Convection grows with air movement; water carries heat away many times faster than air.
    • Evaporation takes about 0.58 kcal per mL, about 700 mL/day insensibly; it is the main defense during exercise and falls as humidity rises.

    Outcome

    1. 18Describe the four routes of heat loss and the physiological determinants of each.
  22. 29.4

    Controlling food intake and energy balance

    • Energy balance means intake matches expenditure; small persistent imbalances store as triglyceride over years.
    • Adipose tissue secretes leptin in proportion to fat stores; leptin and insulin act on the hypothalamus to inhibit eating.
    • When leptin and insulin are low, arcuate neurons release neuropeptide Y, which stimulates intake; melanocortin (MSH) inhibits intake.
    • Satiety signals include rising blood glucose, cholecystokinin and stretch of the stomach and duodenum.

    Outcome

    1. 19Summarize the hypothalamic and hormonal regulation of food intake and energy balance.
  23. 29.4

    Fat-soluble vitamins: A, D, E and K

    • Fat-soluble vitamins are stored in the liver and fat, so excess accumulates; they need normal fat absorption.
    • A: night blindness and dry, keratinized epithelium. D: rickets in children, osteomalacia in adults, because calcium use by bone fails.
    • E: oxidative damage to membranes, with hemolytic anemia a possible consequence.
    • K: needed for liver synthesis of clotting factors including prothrombin; deficiency gives delayed clotting and bleeding.

    Outcome

    1. 20Classify vitamins as fat- or water-soluble and relate each major deficiency or toxicity to its clinical syndrome.
  24. 29.4

    Water-soluble vitamins: B complex and C

    • Water-soluble vitamins are mostly not stored and excess is excreted in urine, so deficiency appears when the supply stops.
    • B1 (thiamine) deficiency gives beriberi, with lactate and pyruvate buildup; niacin deficiency gives pellagra (dermatitis, diarrhea, psychological disturbance).
    • B12 (needs intrinsic factor, absent from plants) and folate deficiency give anemia of large red cells; folate deficiency adds neural tube defects.
    • Vitamin C deficiency impairs collagen and gives scurvy with swollen gums and loosening teeth; B2 and B6 cause skin lesions.

    Outcome

    1. 20Classify vitamins as fat- or water-soluble and relate each major deficiency or toxicity to its clinical syndrome.
  25. 29.1

    Glucose transporters and glycogen storage disorders

    • GLUT1 sets basal uptake in brain and red cells; GLUT2 serves liver, beta cell and gut exit; GLUT3 serves neurons; GLUT4 is insulin-recruited in muscle and fat; GLUT5 takes up fructose.
    • Von Gierke disease is glucose 6-phosphatase deficiency: fasting hypoglycemia, because the liver cannot release free glucose.
    • McArdle disease is muscle glycogen phosphorylase deficiency: exercise cramps, because muscle glycogen cannot be mobilized.

    Outcome

    1. 5Describe glycogenesis, glycogenolysis and gluconeogenesis, including the organs, substrates and the differing fates of liver and muscle glycogen.
  26. 29.1

    Poisons and uncouplers of oxidative phosphorylation

    • Cyanide and carbon monoxide block complex IV, rotenone blocks complex I and antimycin A blocks complex III; electron flow stops and the proton gradient is not built.
    • Oligomycin blocks ATP synthase, so H+ cannot flow back and the chain backs up; uncouplers such as 2,4-dinitrophenol dissipate the gradient as heat.

    Outcome

    1. 3Explain how the electron transport chain and chemiosmotic coupling make ATP, and estimate the total ATP per glucose under aerobic conditions.
  27. 29.2

    Defects of fatty acid oxidation and ketone use

    • Carnitine deficiency or CPT II deficiency cause myopathy and hypoketotic hypoglycemia, since fat cannot be burned or turned to ketones.
    • MCAD deficiency (medium-chain acyl CoA dehydrogenase) presents in infants as fasting hypoglycemia without ketones.
    • The liver lacks succinyl-CoA:acetoacetate CoA transferase (thiophorase), so it makes ketones but cannot use them.
    • Nitroprusside tests detect acetoacetate but not beta-hydroxybutyrate, so they can underestimate ketosis.

    Outcome

    1. 6Describe beta-oxidation of fatty acids, the carnitine shuttle as the rate-limiting step, and the ATP yield from palmitate.
  28. 29.2

    Apolipoprotein detail and lipoprotein disorders

    • Chylomicrons carry apo B-48 (intestine); VLDL and LDL carry apo B-100 (liver); HDL carries apo A-I, which activates LCAT for reverse cholesterol transport.
    • VLDL becomes IDL then LDL as lipoprotein lipase strips triglyceride.
    • Familial hypercholesterolemia is an LDL receptor defect; lipoprotein lipase deficiency raises triglycerides; abetalipoproteinemia lowers them.

    Outcome

    1. 8Compare the lipoprotein classes (chylomicron, VLDL, IDL, LDL, HDL) by origin, main lipid, apolipoproteins and role in lipid transport.
  29. 29.4

    Hypothermia, ECG sign and brown fat

    • Hypothermia is core temperature of 35 C or below; shivering fades at lower temperatures and Osborn J waves can appear on the ECG.
    • Brown fat with UCP1 gives non-shivering thermogenesis in infants and some adults by uncoupling the proton gradient.
    • Staging is approximate and the ranges overlap: mild 32-35 C with shivering, moderate 28-32 C, severe 24-28 C, profound below 24 C.

    Outcome

    1. 16Explain how the hypothalamus senses and regulates body temperature and name the effector responses to heat and to cold.
  30. 29.4

    Eponymous deficiency syndromes and minerals

    • Thiamine deficiency also causes Wernicke-Korsakoff syndrome, common in alcohol use disorder, with lactate rise from impaired pyruvate dehydrogenase.
    • Copper disorders: Wilson disease (copper accumulation) and Menkes disease (copper deficiency); iron deficiency gives microcytic anemia; iodine deficiency gives goiter.

    Outcome

    1. 20Classify vitamins as fat- or water-soluble and relate each major deficiency or toxicity to its clinical syndrome.